ORIC biotech catalysts & pipeline

ORIC PHARMACEUTICALS INC · Data as of 2026-10-27

Upcoming catalysts

enozertinib — Initial data

2H 2026

Anticipate rinzimetostat program update in 2H 2026 and enozertinib clinical updates in 2H 2026 ahead of potential initiation of a registrational trial

Source filing

enozertinib — Conference presentation

Oct 23–Oct 27

October 2026: 1L EGFR atypical monotherapy data to be presented at ESMO Congress 2026

Source filing

Explore the free biotech catalyst calendar